The shift toward precision medicine has altered the landscape of drug development, moving the industry toward therapies tailored to specific biological profiles. The success of these programs depends on the ability to identify, validate, and quantify biological...
The implementation of a cohesive biomarker strategy is one of the most critical elements of getting a drug candidate from early discovery through clinical development. A common pitfall, however, is the assumption that the analytical methods used in early research will...
The transition from a lab concept to a viable clinical drug candidate often relies on accurate measures of biological activity. Biomarker assays serve as these essential yardsticks, providing the data necessary to verify target engagement, assess safety, and predict...
The progression of a therapeutic candidate from preclinical development to clinic readiness depends heavily on the ability to quantify biological responses accurately. While discovery-phase research focuses on identifying potential indicators of efficacy, the...
The term “biomarker” first appeared in a 1947 paper on fetuin-A detection. Biomarkers are defined characteristics measured as indicators of normal biological processes, pathological processes, or biological responses to exposure or drug intervention, including therapeutic interventions.
In preclinical drug development, biomarkers are used to quantify drug safety and response. In this blog, we trace the use of biomarkers across this spectrum with tips along the way. Biomarker analysis is a critical piece of drug development that helps provide a...
Biomarkers In the evolving landscape of drug development, biomarkers are critical tools for assessing drug safety, efficacy, and mechanism of action. At WuXi AppTec, we offer comprehensive biomarker method development and validation services to support programs from...
Bioanalytical method validation is the process of confirming that an analytical method is accurate, precise, and reliable for its intended use in drug development. It ensures that pharmacokinetic, immunogenicity, and biomarker data meet regulatory expectations for IND...
Bioanalytical services play a critical role in determining whether an Investigational New Drug (IND) application proceeds on schedule or encounters delays. The technical execution of a bioanalytical strategy is a critical contributor to the speed of regulatory...
How to deal with toxicology when developing novel therapeutic modalities.
The key safety elements to consider when developing oligonucleotide therapeutics.
Small Molecule Solutions Discover promising small molecule compounds, refine their efficacy and safety properties, and prepare them for IND and NDA submission with WuXi AppTec. With our fully integrated program addressing the bioanalytical, DMPK, and toxicology...
Bioanalytical testing platforms are specific analytical tools that analyze and define the amount of drug molecules in biological fluid.
To make well-informed decisions about the future of your drug candidate, you need highly accurate and reliable data. Generating such data starts with bioanalytical method development and validation – a precise process that requires support from your testing partner....
To be effective and safe, a therapy must contain precise drug concentration. That’s why bioanalytical testing is required during the drug development process. For robust and accurate data, bioanalytical testing relies on effective method development and validation. In...
Trade Articles GET A QUOTE Life Science Daily News | May 2026 Modernizing Safety: The Predictive Power of In Vitro Toxicology ONdrugDelivery | May 2026 Transdermal Drug Delivery: Enhancing Permeability and In Vivo Translation Contract Pharma | May 2026...